Overview

Evaluation of the Efficacy of Contrast Enhanced Ultrasound Compared to MRI for Differentiation of Hepatic Lesions

Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
0
Participant gender:
All
Summary
In patients with hepatic lesions, to evaluate the efficacy of contrast enhanced ultrasound compared to MRI in differentiating focal nodular hyperplasia and hepatic adenoma.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Indiana University
Criteria
Inclusion Criteria:

1. Males and females

2. Age 18 years or greater

3. Scheduled to undergo abdominal MRI with contrast at a performance site for evaluation
of a hepatic lesion(s).

Exclusion criteria:

1. History of cardiac shunting

2. History of acute cardiac ischemia

3. History of hypersensitivity reaction to Lumason